VIVUS, Inc.
(NASDAQ : VVUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading VVUS News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.81%15.7814.2%$301.90m
SHPGShire PLC Sponsored ADR
-1.11%172.980.4%$213.79m
PRGOPerrigo Co. Plc
0.83%75.276.4%$143.86m
PRXLPAREXEL International Corporation
-0.36%86.807.9%$136.24m
MNKMallinckrodt Plc
2.12%46.3317.7%$126.60m
ALRAlere Inc.
-0.10%50.182.7%$93.63m
JAZZJazz Pharmaceuticals Plc
-0.43%158.802.2%$84.49m
UTHRUnited Therapeutics Corporation
-0.08%131.5913.9%$76.26m
ENDPEndo International Plc
1.63%11.848.9%$73.99m
PTLAPortola Pharmaceuticals, Inc.
46.75%56.138.9%$69.62m
HZNPHorizon Pharma plc
-1.22%11.737.6%$57.17m
AERIAerie Pharmaceuticals, Inc.
-0.45%54.808.9%$55.00m
ICPTIntercept Pharmaceuticals, Inc.
1.32%132.2922.1%$52.53m
MDCOMedicines Company
1.18%38.6022.3%$51.68m
CTLTCatalent Inc
-1.53%37.222.8%$40.04m

Company Profile

VIVUS, Inc. operates as a biopharmaceutical company engages in the development and commercialization of novel therapeutic products. It offers the Qsymia for chronic weight management, as well as STENDRA and SPEDRA for erectile dysfunction. Its development also include Tacrolimus which is for the treatment of Pulmonary Arterial Hypertension. The company was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.,0016S1-E